Health SA Gesondheid (Online)
versión On-line ISSN 2071-9736
versión impresa ISSN 1025-9848
RAZLOG, Radmila; PELLOW, Janice y WHITE, Sally J.. A pilot study on the efficacy of Valeriana officinalis mother tincture and Valeriana officinalis 3X in the treatment of attention deficit hyperactivity disorder. Health SA Gesondheid (Online) [online]. 2012, vol.17, n.1, pp.1-7. ISSN 2071-9736.
Attention deficit hyperactivity disorder (ADHD) is an increasingly prevalent behavioural disorder characterised by inattention, impulsivity and hyperactivity. Valeriana officinalis is a botanical medicine that has been found to be beneficial in the treatment of disorders characterised by restlessness. To date, no research has been conducted on homeopathic preparations of Valeriana officinalis for this condition. The aim of this three-week, double-blind, placebo-controlled pilot study was to determine the efficacy of homeopathic Valeriana officinalis mother tincture (MT) and 3X potency on ADHD. Thirty children between the ages of five and 11 years, pre-diagnosed with ADHD, were recruited. Valeriana officinalis MT (n = 10), 3X (n = 10) or placebo (n = 10) were administered orally three times a day for two weeks. Efficacy was assessed by the Barkley and DuPaul teacher rating scale, the children's checking task and the parent symptom questionnaire scores on day 1 (prior to treatment), at the end of weeks two and three (with treatment), and then after the third week following no treatment. A statistically significant improvement was found in the participants' behaviour in the MT and 3X groups, with particular reference to sustained attention, anxiety and impulsivity and/or hyperactivity. Preliminary findings suggested that Valeriana officinalis MT and 3X may have applications in the management of ADHD.